[Supportive management of cisplatin and gemcitabine combination therapy for advanced biliary tract cancer]

Nihon Rinsho. 2015 Feb:73 Suppl 2:592-6.
[Article in Japanese]
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Biliary Tract Neoplasms / drug therapy*
  • Biliary Tract Neoplasms / pathology
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Clinical Trials as Topic
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives
  • Gemcitabine
  • Humans
  • Neoplasm Staging

Substances

  • Antineoplastic Agents
  • Deoxycytidine
  • Cisplatin
  • Gemcitabine